Genomics and Precision Health Posts
Genetic testing in children has traditionally focused on conditions with clinical actionability or utility. However, parents may want to know whether their child is at high risk of a rare disease even if a treatment doesn’t exist. A newly published article reports on a study conducted by researchers at RTI International and the University of Read More >Posted on by
Genomics and Obesity: We Need Both Population and Individualized Approaches in the Prevention and Management of Obesity
Obesity is a serious, global public health problem that has increased markedly in the last few decades. As of 2016, 795 million people were estimated to have been affected. Obesity is associated with leading causes of death worldwide—such as diabetes, cardiovascular disease, and cancer—making the search for effective weight management strategies a global priority. Obesity Read More >Posted on by
The Impact of Family History on the Public Health Burden of Diagnosed Diabetes, Undiagnosed Diabetes and Prediabetes in the United States: Using Family History for Diabetes Control and Prevention
This blog post is a summary of our recently published paper in Genetics in Medicine. Type 2 diabetes is a major public health problem in the United States and globally. Among adults 20 years and older, 9.2% have diagnosed diabetes (DD), 3.1% have undiagnosed diabetes (UD), and 36% have prediabetes (PD), a major precursor for Read More >Posted on by
Public health genomics is a relatively young field concerned with the effective and responsible translation of genomic science into population health benefits. In the past few years, the field has witnessed the emergence of several state public health genomics programs beyond the traditional domain of newborn screening. The field has focused on preventing disease and Read More >Posted on by
Public health genomics advances the translation of genome-based discoveries into disease prevention and population health. Scientists at the Centers for Disease Control and Prevention (CDC) are using information about human, vector, and pathogen genomes to tackle diverse public health problems, from newborn metabolic disorders to infectious disease outbreaks. For an overview of CDC publications in Read More >Posted on by
This December, we are especially excited as we anticipate the dawning of a bright new year. The ebbing of 2017 marks the end of, not just another year, but two decades of public health genomics. Recently we were provided two valuable opportunities to place a capstone on this important milestone. Last month, at the American Read More >Posted on by
As the evidence base for genomic medicine grows, evaluating and implementing genomics to improve health care and population health remains an ongoing challenge. There is no guarantee that “if we build it they will come,” paraphrasing the well-known expression from the movie, Field of Dreams. To improve adoption, uptake and sustainability of genomic medicine applications, Read More >Posted on by
The amount of emerging genomic information related to healthcare and public health is staggering. PHGKB is a one-stop shop for information relevant to genomics translation and population health impact for almost all diseases across the life span. MyPHGKB allows end users to customize their own PHGKB databases and type of information. The Public Health Genomics Read More >Posted on by
Happy Thanksgiving 2017: Take time to collect, share, and act on your family health history, it may save your life!
Regular readers of this blog may have noticed that we have an almost identical message around each Thanksgiving Day. Collect, share, and act on your family health history! It seems every year we emphasize a slightly different version of this message. In 2016, we highlighted the emergence of new tools that can help consumers and Read More >Posted on by
Genomics and Precision Medicine: How Can Emerging Technologies Address Population Health Disparities? Join the Conversation.
Advances in genome sequencing, other “omic” technologies, and big data promise a new era of personalized medicine. However, there is an ongoing discussion how these new technologies can be used to understand and address existing population health disparities. On October 11, 2017, the Precision Medicine and Population Health Interest Group in the Division of Cancer Read More >Posted on by
- Content source: